Review the following distinct laboratory profiles regarding calcium and phosphorus metabol… — USMLE Step 2 CK

Review the following distinct laboratory profiles regarding calcium and phosphorus metabolism. Match each patient's serum and urine laboratory findings to the most accurate underlying pathophysiologic mechanism.

Serum calcium $11.8$ mg/dL, phosphorus $2.2$ mg/dL, intact PTH $9$ pg/mL (low). Elevated PTH-related peptide.Ectopic production of a peptide mimicking parathyroid hormone action
Serum calcium $11.5$ mg/dL, phosphorus $2.4$ mg/dL, intact PTH $85$ pg/mL (high). Elevated $24$ -hour urinary calcium excretion.Autonomous neoplastic proliferation of chief cells lacking feedback inhibition
Serum calcium $11.1$ mg/dL, intact PTH $65$ pg/mL (high-normal). Urine calcium-to-creatinine clearance ratio is $0.005$ .Inactivating mutation of the calcium-sensing receptor
Serum calcium $11.8$ mg/dL, phosphorus $4.6$ mg/dL, intact PTH $8$ pg/mL (low). Elevated $1,25$ -dihydroxyvitamin D.Unregulated ectopic production of $1$ -alpha-hydroxylase by tissue macrophages
Serum calcium $7.9$ mg/dL, phosphorus $6.2$ mg/dL, intact PTH $410$ pg/mL (high). Decreased $1,25$ -dihydroxyvitamin D.Impaired renal phosphate excretion and decreased $1$ -alpha-hydroxylase activity

Answer

Successfully matched all five clinical laboratory profiles to their defining pathophysiologic mechanisms based on calcium, phosphorus, PTH, and vitamin D axes.

Each laboratory pattern distinctively corresponds to a classic endocrine pathology. Ectopic PTHrP causes humoral hypercalcemia of malignancy (high Ca, low PTH). Autonomous parathyroid adenomas cause primary hyperparathyroidism (high Ca, high PTH, high urine Ca). Calcium-sensing receptor mutations cause FHH (high Ca, normal/high PTH, very low urine Ca clearance). Macrophage-driven 1-alpha-hydroxylase activity in granulomas causes vitamin D toxicity (high Ca, high phos, low PTH). Chronic kidney disease causes secondary hyperparathyroidism (low Ca, high phos, high PTH).

Step-by-Step Solution

Analyze profile 1 (Hypercalcemia, low PTH, high PTHrP).

Matches ectopic production of a peptide mimicking parathyroid hormone action.

PTHrP acts on the PTH receptor to increase calcium and decrease phosphorus, but it does not cross-react in the intact PTH assay, leading to suppressed endogenous PTH.

Analyze profile 2 (Hypercalcemia, high PTH, high urine calcium).

Matches autonomous neoplastic proliferation of chief cells.

Elevated PTH despite hypercalcemia, coupled with hypercalciuria, indicates primary hyperparathyroidism without a calcium-sensing defect.

Analyze profile 3 (Hypercalcemia, normal/high PTH, low urine calcium clearance).

Matches inactivating mutation of the calcium-sensing receptor.

Familial hypocalciuric hypercalcemia alters the set-point for calcium sensing in the parathyroids and kidneys, causing hypercalcemia with relative hypocalciuria.

Analyze profile 4 (Hypercalcemia, high phosphorus, low PTH, high 1,25-OH Vit D).

Matches unregulated ectopic production of 1-alpha-hydroxylase by tissue macrophages.

Granulomatous diseases cause PTH-independent conversion of 25-OH to 1,25-OH vitamin D, causing high calcium and high phosphorus with appropriately suppressed PTH.

Analyze profile 5 (Hypocalcemia, high phosphorus, very high PTH).

Matches impaired renal phosphate excretion and decreased 1-alpha-hydroxylase activity.

Chronic kidney disease causes phosphate retention and decreased active vitamin D, leading to hypocalcemia and a robust secondary rise in PTH.

Key Concept

Differential diagnosis of calcium and phosphorus metabolic disorders based on parathyroid hormone and vitamin D dynamics.

Question

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Topics

More questions from this topic